Pro Dex director Raymond Cabillot sells shares worth $371,988
E. Cabillot, a director and ten percent owner of Pro Dex Inc. (NASDAQ:PDEX), recently sold a significant number of shares in the company. The sale comes as Pro Dex shares have surged over 112% in the ...
Hosted on MSN5h
SurGenTec receives FDA clearance for synthetic bone graft material
SurGenTec asserts that the OsteoFlo HydroFiber may improve patient outcomes versus the use of allograft/autograft in spinal surgeries.
Contract Pharma3d
Hikma Partners with Emergent for the Sale of KLOXXADO in the U.S. & Canada
Hikma Pharmaceuticals PLC, the multinational pharmaceutical group, has entered an exclusive commercial partnership with ...